Common Contracts
10 similar Exchange Agreement contracts by Quidel Corp /De/, Immunogen Inc, Immunomedics Inc, others
Form of Exchange AgreementExchange Agreement • November 24th, 2020 • Tilray, Inc. • Medicinal chemicals & botanical products • Delaware
This Exchange Agreement and the Terms and Conditions for Exchange of Securities, attached hereto as Exhibit A (the “Terms and Conditions” and, together with this Exchange Agreement, the “Agreement”), is made as of the date hereof between Tilray, Inc. (the “Company”) and the Investor (as defined below).
Standard Contracts
EX-10.1 2 a17-21239_1ex10d1.htm EX-10.1 Form of Exchange Agreement August 31, 2017 ImmunoGen, Inc. Waltham, MA 02451 Attn: David B. Johnston Re: Exchange of 4.50% Convertible Senior Notes due 2021 for Common Stock Ladies and Gentlemen: The undersigned...Exchange Agreement • May 5th, 2020 • New York
This Exchange Agreement and the Terms and Conditions for Exchange of Securities, dated August 31, 2017, attached hereto as Exhibit A (the “Terms and Conditions” and, together with this Exchange Agreement, the “Agreement”) is made as of the date hereof between the Company and the Investor.
Exchange AgreementExchange Agreement • December 11th, 2019 • Par Pacific Holdings, Inc. • Crude petroleum & natural gas • New York
This Exchange Agreement and the Terms and Conditions for Exchange of Securities attached hereto as Exhibit A (the “Terms and Conditions” and, together with this Exchange Agreement, the “Agreement”) is made as of the date hereof between the Company and the Investor. Capitalized terms used but not defined in this Agreement have the respective meanings set forth in the indenture, dated as of June 21, 2016, between the Company and Wilmington Trust, National Association (the “Indenture”).
Exchange AgreementExchange Agreement • June 5th, 2019 • Quidel Corp /De/ • In vitro & in vivo diagnostic substances • New York
This Exchange Agreement and the Terms and Conditions for Exchange of Securities, dated June 4, 2019, attached hereto as Exhibit A (the “Terms and Conditions” and, together with this Exchange Agreement, this “Agreement”) is made as of the date hereof between the Company and the Investor.
Form of Exchange AgreementExchange Agreement • November 7th, 2018 • Immunomedics Inc • In vitro & in vivo diagnostic substances • New York
This Exchange Agreement and the Terms and Conditions for Exchange of Securities, dated October 2, 2018, attached hereto as Exhibit A (the “Terms and Conditions” and, together with this Exchange Agreement, the “Agreement”) is made as of the date hereof between the Company and the Investor.
Exchange AgreementExchange Agreement • June 1st, 2018 • Quidel Corp /De/ • In vitro & in vivo diagnostic substances • New York
This Exchange Agreement and the Terms and Conditions for Exchange of Securities, dated May 31, 2018, attached hereto as Exhibit A (the “Terms and Conditions” and, together with this Exchange Agreement, this “Agreement”) is made as of the date hereof between the Company and the Investor.
Exchange AgreementExchange Agreement • March 9th, 2018 • Quidel Corp /De/ • In vitro & in vivo diagnostic substances • New York
This Exchange Agreement and the Terms and Conditions for Exchange of Securities, dated March 8, 2018, attached hereto as Exhibit A (the “Terms and Conditions” and, together with this Exchange Agreement, this “Agreement”) is made as of the date hereof between the Company and the Investor.
Exchange AgreementExchange Agreement • September 26th, 2017 • Immunogen Inc • Pharmaceutical preparations • New York
This Exchange Agreement and the Terms and Conditions for Exchange of Securities, dated September [ ], 2017, attached hereto as Exhibit A (the “Terms and Conditions” and, together with this Exchange Agreement, the “Agreement”) is made as of the date hereof between the Company and the Investor.
Form of Exchange AgreementExchange Agreement • September 15th, 2017 • Immunomedics Inc • In vitro & in vivo diagnostic substances • New York
This Exchange Agreement and the Terms and Conditions for Exchange of Securities, dated September 14, 2017, attached hereto as Exhibit A (the “Terms and Conditions” and, together with this Exchange Agreement, the “Agreement”) is made as of the date hereof between the Company and the Investor.
Form of Exchange AgreementExchange Agreement • September 1st, 2017 • Immunogen Inc • Pharmaceutical preparations • New York
This Exchange Agreement and the Terms and Conditions for Exchange of Securities, dated August 31, 2017, attached hereto as Exhibit A (the “Terms and Conditions” and, together with this Exchange Agreement, the “Agreement”) is made as of the date hereof between the Company and the Investor.
